• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在共同的肝移植等待名单中,为有或没有肝细胞癌的候选者建立失访评估模型。

A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.

机构信息

Division of Transplant, Department of Surgery, University of Geneva Hospitals, Geneva, Switzerland.

出版信息

Hepatology. 2012 Jul;56(1):149-56. doi: 10.1002/hep.25603. Epub 2012 Jun 18.

DOI:10.1002/hep.25603
PMID:22271250
Abstract

UNLABELLED

In many countries, the allocation of liver grafts is based on the Model of End-stage Liver Disease (MELD) score and the use of exception points for patients with hepatocellular carcinoma (HCC). With this strategy, HCC patients have easier access to transplantation than non-HCC ones. In addition, this system does not allow for a dynamic assessment, which would be required to picture the current use of local tumor treatment. This study was based on the Scientific Registry of Transplant Recipients and included 5,498 adult candidates of a liver transplantation for HCC and 43,528 for non-HCC diagnoses. A proportional hazard competitive risk model was used. The risk of dropout of HCC patients was independently predicted by MELD score, HCC size, HCC number, and alpha-fetoprotein. When combined in a model with age and diagnosis, these factors allowed for the extrapolation of the risk of dropout. Because this model and MELD did not share compatible scales, a correlation between both models was computed according to the predicted risk of dropout, and drop-out equivalent MELD (deMELD) points were calculated.

CONCLUSION

The proposed model, with the allocation of deMELD, has the potential to allow for a dynamic and combined comparison of opportunities to receive a graft for HCC and non-HCC patients on a common waiting list.

摘要

目的

在许多国家,肝移植的分配基于终末期肝病模型(MELD)评分和对肝细胞癌(HCC)患者使用例外积分。采用该策略,HCC 患者比非 HCC 患者更容易获得移植。此外,该系统不允许进行动态评估,而这是需要对当前局部肿瘤治疗的使用情况进行评估所必需的。

方法

本研究基于移植受者科学登记处,纳入了 5498 名 HCC 成人肝移植候选者和 43528 名非 HCC 诊断候选者。采用比例风险竞争风险模型。MELD 评分、HCC 大小、HCC 数量和甲胎蛋白独立预测 HCC 患者失访的风险。当将这些因素与年龄和诊断结合在一个模型中时,允许外推失访的风险。由于该模型和 MELD 没有共享兼容的范围,因此根据预测的失访风险计算了这两个模型之间的相关性,并计算了失访等效 MELD(deMELD)点。

结论

该模型和 deMELD 的分配有可能允许对 HCC 和非 HCC 患者在普通等候名单上获得移植的机会进行动态和联合比较。

相似文献

1
A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.在共同的肝移植等待名单中,为有或没有肝细胞癌的候选者建立失访评估模型。
Hepatology. 2012 Jul;56(1):149-56. doi: 10.1002/hep.25603. Epub 2012 Jun 18.
2
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.七十岁以上患者接受终末期肝病模型例外点用于肝细胞癌的肝移植:全国经验。
Liver Transpl. 2012 Apr;18(4):423-33. doi: 10.1002/lt.23385.
3
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.在终末期肝病模型系统内针对等待肝移植的肝细胞癌患者的一项新的优先政策。
Liver Transpl. 2007 Jun;13(6):857-66. doi: 10.1002/lt.21155.
4
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.一种在共同的肝移植等待名单上为肝癌患者和非肝癌患者分配公平性的方法。
J Hepatol. 2014 Feb;60(2):290-7. doi: 10.1016/j.jhep.2013.10.010. Epub 2013 Oct 23.
5
MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.MELDEQ:一种用于肝细胞癌患者的终末期肝病评分替代模型。
Liver Transpl. 2015 May;21(5):612-22. doi: 10.1002/lt.24098. Epub 2015 Apr 15.
6
Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list.普通肝移植等待名单上肝细胞癌患者与非肝细胞癌患者退出评估模型的验证
Transpl Int. 2014 Jul;27(7):686-95. doi: 10.1111/tri.12323. Epub 2014 Apr 25.
7
Liver transplantation for hepatocellular carcinoma: the MELD impact.肝细胞癌的肝移植:终末期肝病模型(MELD)的影响
Liver Transpl. 2004 Jan;10(1):36-41. doi: 10.1002/lt.20012.
8
An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.对器官共享联合网络(UNOS)肝脏移植登记处的分析:高血清甲胎蛋白并不足以证明因疑似肝细胞癌而增加终末期肝病模型(MELD)评分是合理的。
Liver Transpl. 2006 Oct;12(10):1519-22. doi: 10.1002/lt.20859.
9
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.肝细胞癌的肝移植:终末期肝病模型(MELD)分配系统的影响及生存预测因素
Gastroenterology. 2008 May;134(5):1342-51. doi: 10.1053/j.gastro.2008.02.013. Epub 2008 Feb 13.
10
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.终末期肝病评分模型是人类免疫缺陷病毒1感染的终末期肝病患者最佳的预后因素:一项前瞻性队列研究。
Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

引用本文的文献

1
The Italian Score for Organ Allocation: A Ten-Year Monocentric Retrospective Analysis in Liver Transplantation for Hepatocellular Carcinoma.意大利器官分配评分:肝细胞癌肝移植十年单中心回顾性分析
Cancers (Basel). 2025 May 21;17(10):1720. doi: 10.3390/cancers17101720.
2
Model of Urgency for Liver Transplantation in Hepatocellular Carcinoma: A Practical Model to Prioritize Patients With Hepatocellular Carcinoma on the Liver Transplant Waitlist.肝细胞癌肝移植紧迫性模型:一种在肝移植等待名单上对肝细胞癌患者进行优先排序的实用模型。
Gastroenterology. 2025 Apr;168(4):784-794.e4. doi: 10.1053/j.gastro.2024.11.015. Epub 2024 Nov 30.
3
Predicting waitlist dropout in hepatocellular carcinoma: a narrative review.
预测肝细胞癌患者在等待名单上的退出情况:一项叙述性综述。
Transl Gastroenterol Hepatol. 2024 Aug 21;9:72. doi: 10.21037/tgh-24-24. eCollection 2024.
4
Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma.肝细胞癌患者和非肝细胞癌患者接受肝移植的生存获益。
JHEP Rep. 2023 Sep 13;5(12):100907. doi: 10.1016/j.jhepr.2023.100907. eCollection 2023 Dec.
5
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications.揭示EPH/ Ephrin信号通路在肝癌中的意义:对肿瘤进展及治疗意义的见解
Cancers (Basel). 2023 Jun 30;15(13):3434. doi: 10.3390/cancers15133434.
6
Magnetic Resonance Imaging Predictors of Hepatocellular Carcinoma Progression and Dropout in Patients in Liver Transplantation Waiting List.肝移植等待名单上患者肝细胞癌进展和退出的磁共振成像预测因素
Transplant Direct. 2022 Oct 18;8(11):e1365. doi: 10.1097/TXD.0000000000001365. eCollection 2022 Nov.
7
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma.AFP SCORE 进展是符合肝癌肝移植标准的患者发生微血管侵犯的术前预测因素。
Transpl Int. 2022 Mar 23;35:10412. doi: 10.3389/ti.2022.10412. eCollection 2022.
8
Radiofrequency ablation in the management of primary hepatic and biliary tumors.原发性肝脏和胆道肿瘤治疗中的射频消融术。
World J Gastrointest Oncol. 2022 Jan 15;14(1):203-215. doi: 10.4251/wjgo.v14.i1.203.
9
Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma.机器学习预测肝癌肝移植候选者的候补名单脱落率。
Cancer Med. 2022 Mar;11(6):1535-1541. doi: 10.1002/cam4.4538. Epub 2022 Jan 14.
10
A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.一种用于肝细胞癌的新的候补者退出评分 - 确定一个可预测移植后生存状况更差的阈值。
J Hepatol. 2021 Apr;74(4):829-837. doi: 10.1016/j.jhep.2020.10.033. Epub 2020 Nov 11.